Their insulin-independent mechanism of action inhibits sodium–glucose co-transporters, thus decreasing the renal glucose threshold (to ~ 100 mg/dL) and promoting urinary glucose excretion, without increasing the risk of hypoglycemia. The gene discussed is INS; the disease is Hypoglycemia.